Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Longboard Pharmaceuticals, Inc. LBPH
$9.16
-$0.67 (-7.29%)
На 18:04, 12 мая 2023
+74.67%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
229894740.00000000
-
week52high
9.65
-
week52low
2.70
-
Revenue
0
-
P/E TTM
-4
-
Beta
1.05954400
-
EPS
-2.46000000
-
Last Dividend
0.00000000
-
Next Earnings Date
02 авг 2023 г. в 10:59
Описание компании
Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. Its preclinical product candidates include LP659 and LP143, which focuses on developing therapies for multiple neurological diseases. The company was formerly known as Arena Neuroscience, Inc. and changed its name to Longboard Pharmaceuticals, Inc. in October 2020. Longboard Pharmaceuticals, Inc. was incorporated in 2020 and is based in La Jolla, California.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| HC Wainwright & Co. | Buy | 27 апр 2022 г. | |
| Wedbush | Outperform | 14 февр 2022 г. | |
| Evercore ISI Group | Outperform | 07 апр 2021 г. | |
| Guggenheim | Buy | 06 апр 2021 г. | |
| Citigroup | Buy | 06 апр 2021 г. | |
| Guggenheim | Buy | Buy | 11 ноя 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Tiller Jane | A | 12367 | 12367 | 24 мая 2022 г. |
| SCHNEIDER PHILLIP M | A | 12367 | 12367 | 24 мая 2022 г. |
| SEKHRI PAUL J | A | 12367 | 12367 | 24 мая 2022 г. |
| Lynch Casey | A | 12367 | 12367 | 24 мая 2022 г. |
| Le Goff Corinne | A | 12367 | 12367 | 24 мая 2022 г. |
| Aurentz Vincent | A | 12367 | 12367 | 24 мая 2022 г. |
| Kaye Randall | A | 206500 | 206500 | 21 мар 2022 г. |
| Perera Philip | A | 95000 | 95000 | 09 февр 2022 г. |
| Roberts Brandi | A | 90000 | 90000 | 09 февр 2022 г. |
| Lind Kevin Robert | A | 195000 | 195000 | 09 февр 2022 г. |
Новостная лента
Longboard Pharmaceuticals: Arena Team's Next Act Is Flying Under The Radar
Seeking Alpha
23 ноя 2022 г. в 10:32
Shares have fallen by nearly 70% since IPO. Leadership including President & CEO hails from Arena Pharmaceuticals (bought out by Pfizer for $6.7B last year, which still owns 23% of Longboard).
Longboard Pharmaceuticals to Present at Guggenheim's Healthcare Talks 4th Annual Immunology and Neurology Day
Business Wire
08 ноя 2022 г. в 08:30
LA JOLLA, Calif.
Longboard Pharmaceuticals to Participate in Upcoming Investor Conferences
GlobeNewsWire
01 сент 2022 г. в 16:01
SAN DIEGO, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that members of its senior leadership team will participate in the Citi Annual BioPharma Conference, which is taking place September 7-8, 2022, in Boston, MA, and participate in a fireside chat at the H.C. Wainwright Global Investment Conference, which is taking place September 12-14, 2022, in New York City.
2 ‘strong buy' penny stocks with over 300% possible upside
Finbold
19 авг 2022 г. в 04:28
Penny stocks are shares usually below $5, representing small companies, most of which trade by over-the-counter (OTC) transactions, while there
Longboard Pharmaceuticals to Present at the 2022 Wedbush PacGrow Healthcare Virtual Conference
GlobeNewsWire
03 авг 2022 г. в 08:30
SAN DIEGO, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that Brandi Roberts, Longboard's Chief Financial Officer, will present as a panelist at the Wedbush PacGrow Healthcare Virtual Conference on August 10, 2022, at 12:35PM ET.